Chemoinformaics analysis of N-acetylsepaconitine
| Molecular Weight | 600.709 | nRot | 7 |
| Heavy Atom Molecular Weight | 556.357 | nRig | 32 |
| Exact Molecular Weight | 600.305 | nRing | 7 |
| Solubility: LogS | -3.698 | nHRing | 1 |
| Solubility: LogP | 1.788 | No. of Aliphatic Rings | 6 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 5 |
| Atoms Count | 87 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 43 | No. of Aromatic Carbocycles | 1 |
| nHetero | 11 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 7 | No. Saturated Carbocycles | 5 |
| No. of Hydrogen atom | 44 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 32 | No. of Saturated Rings | 6 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 6 |
| nHA | 10 | APOL | 92.1969 |
| nHD | 4 | BPOL | 55.1011 |
| QED | 0.338 |
| Synth | 7.246 |
| Natural Product Likeliness | 2.124 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.771 |
| Pgp-sub | 0.999 |
| HIA | 0.73 |
| CACO-2 | -5.606 |
| MDCK | 0.0000474 |
| BBB | 0.156 |
| PPB | 0.172043 |
| VDSS | 0.541 |
| FU | 0.617105 |
| CYP1A2-inh | 0.006 |
| CYP1A2-sub | 0.879 |
| CYP2c19-inh | 0.007 |
| CYP2c19-sub | 0.476 |
| CYP2c9-inh | 0.006 |
| CYP2c9-sub | 0.005 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.161 |
| CYP3a4-inh | 0.114 |
| CYP3a4-sub | 0.656 |
| CL | 4.786 |
| T12 | 0.18 |
| hERG | 0.308 |
| Ames | 0.065 |
| ROA | 0.165 |
| SkinSen | 0.562 |
| Carcinogencity | 0.872 |
| EI | 0.009 |
| Respiratory | 0.985 |
| NR-Aromatase | 0.908 |
| Antiviral | Yes |
| Prediction | 0.863057 |